|
FY2025
12 months to Oct 3, 2025
|
FY2024
12 months to Sep 27, 2024
|
FY2023
12 months to Sep 29, 2023
|
FY2022
12 months to Sep 30, 2022
|
FY2021
12 months to Oct 1, 2021
|
|
|---|---|---|---|---|---|
| Revenues, net | |||||
| Cost of revenues | |||||
| Gross profit | |||||
| Operating expenses: | |||||
| Research and development | |||||
| Selling, general, and administrative | |||||
| Impairment of intangible assets | |||||
| Impairment of goodwill | |||||
| Total operating expenses | |||||
| Operating (loss) income | |||||
| Interest income | |||||
| Interest expense | |||||
| Other expense, net | |||||
| Interest and other expense, net | |||||
| (Loss) income before taxes | |||||
| Income tax expense (benefit) | |||||
| Net (loss) income | |||||
| Less: Net income attributable to noncontrolling interests | |||||
| Net (loss) income attributable to Varex | |||||
| Net (loss) income per common share attributable to Varex | |||||
| Basic (in USD per share) | |||||
| Diluted (in USD per share) | |||||
| Weighted average common shares outstanding | |||||
| Basic (in shares) | |||||
| Diluted (in shares) |
Loading...
